OBJECTIVE: This study aims to investigate the prevalence of psychiatric disorders, i.e., the presence of signs and symptoms of anxiety and depression in type 1 diabetic patients, as well as to investigate the prevalence of psychiatric disorders in insulin dependent patients. METHODS: A cross-sectional observational study of 110 diabetic outpatients (mean = 58.3, SD = 14.5; 50 male and 60 female) was conducted in a public health clinic with patients diagnosed with diabetes mellitus who were under the medical supervision of an endocrinologist. The patients were evaluated through the Mini International Neuropsychiatric Interview and the Hospital Anxiety and Depression Scale(HADS). RESULTS: With respect to anxiety symptoms, we found a prevalence of 60% (n = 66) among patients, while in depression symptoms we found a prevalence of 53.6% (n = 59) concerning the 110 patients evaluated. More specifically, we found 28.2% (n = 31) of patients without depression or anxiety, 13.6% (n = 15) of patients with depression, 16.4% (n = 18) of patients with anxiety and 41.8% (n = 46) of patients with depression combined with anxiety. The most remarkable data were generalized anxiety disorder (22.7%), dysthymia (18.2%), panic disorder (8.2%) and social phobia (5.5%). CONCLUSION: The need for accurate assessments about the presence of symptoms related to psychopathology in patients with type 1 diabetes is evident.
OBJECTIVE: This study aims to investigate the prevalence of psychiatric disorders, i.e., the presence of signs and symptoms of anxiety and depression in type 1 diabeticpatients, as well as to investigate the prevalence of psychiatric disorders in insulin dependent patients. METHODS: A cross-sectional observational study of 110 diabetic outpatients (mean = 58.3, SD = 14.5; 50 male and 60 female) was conducted in a public health clinic with patients diagnosed with diabetes mellitus who were under the medical supervision of an endocrinologist. The patients were evaluated through the Mini International Neuropsychiatric Interview and the Hospital Anxiety and Depression Scale(HADS). RESULTS: With respect to anxiety symptoms, we found a prevalence of 60% (n = 66) among patients, while in depression symptoms we found a prevalence of 53.6% (n = 59) concerning the 110 patients evaluated. More specifically, we found 28.2% (n = 31) of patients without depression or anxiety, 13.6% (n = 15) of patients with depression, 16.4% (n = 18) of patients with anxiety and 41.8% (n = 46) of patients with depression combined with anxiety. The most remarkable data were generalized anxiety disorder (22.7%), dysthymia (18.2%), panic disorder (8.2%) and social phobia (5.5%). CONCLUSION: The need for accurate assessments about the presence of symptoms related to psychopathology in patients with type 1 diabetes is evident.
Authors: Hanna Kampling; Frank Petrak; Erik Farin; Bernd Kulzer; Stephan Herpertz; Oskar Mittag Journal: Diabetologia Date: 2016-10-27 Impact factor: 10.122
Authors: Azubuike P Ebokaiwe; Stephen Okori; Joseph O Nwankwo; Chukwunonso E C C Ejike; Sharon O Osawe Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2020-10-16 Impact factor: 3.000
Authors: Michiel F Nijhoff; Jacqueline G F M Hovens; Sasja D Huisman; Jan Ringers; Ton A J Rabelink; Hans J W de Fijter; Paul J M van der Boog; Eelco J P de Koning Journal: Transplant Direct Date: 2020-04-27